Understanding the role of rituximab in ANCA GN: regressing toward the mean
- PMID: 25381425
- PMCID: PMC4378114
- DOI: 10.1681/ASN.2014100997
Understanding the role of rituximab in ANCA GN: regressing toward the mean
Keywords: ANCA; B cells; remission induction.
Figures
Comment on
-
Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement.J Am Soc Nephrol. 2015 Apr;26(4):976-85. doi: 10.1681/ASN.2014010046. Epub 2014 Nov 7. J Am Soc Nephrol. 2015. PMID: 25381429 Free PMC article. Clinical Trial.
References
-
- Kallenberg CG, Stegeman CA, Abdulahad WH, Heeringa P: Pathogenesis of ANCA-associated vasculitis: New possibilities for intervention. Am J Kidney Dis 62: 1176–1187, 2013 - PubMed
-
- Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U; RAVE-ITN Research Group: Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363: 221–232, 2010 - PMC - PubMed
-
- Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Fessler BJ, Ding L, Viviano L, Tchao NK, Phippard DJ, Asare AL, Lim N, Ikle D, Jepson B, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Mueller M, Sejismundo LP, Mieras K, Stone JH; RAVE-ITN Research Group: Efficacy of remission-induction regimens for ANCA-associated vasculitis. N Engl J Med 369: 417–427, 2013 - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources